Decisions about which type of patients receive what interventions, when, and at what cost often result from ad hoc, nontransparent processes driven more by inertia and interest groups than by science, ethics, and the public interest. Reallocating a portion of public and donor monies toward the most cost-effective health interventions would save more lives and promote health equity.
- (-) Remove Kalipso Chalkidou filter Kalipso Chalkidou
- (-) Remove Global Health Policy filter Global Health Policy
- (-) Remove Corruption, Transparency, and Governance filter Corruption, Transparency, and Governance
Filter by publication type:
June 11, 2012